Out-of-pocket health expenditure by Colombian households rose 57.3 percent between 2022 and 2025, with the poorest quintile bearing a 63.4 percent increase against just 15.3 percent for the wealthiest. The data, released by the pharmaceutical research association Afidro, trace the effect to mounting access barriers: delayed appointments, undelivered medicines, and insurer resource shortages that push patients to fund care themselves. Among low-income Colombians, 60.3 percent reported not receiving prescribed medicines because of unavailability, and the share turning to self-medication doubled to 18 percent over the same period.

Viewed from Bogotá, the household strain mirrors a wider fiscal squeeze. The government’s Medium-Term Fiscal Framework projects a deficit of 5.3 percent of GDP for 2026, but the think tank Fedesarrollo calculates the required adjustment is larger once accumulated health and energy obligations are recognised. The framework assumes spending cuts and revenue gains it does not specify, while unreimbursed fuel-price subsidies and the automatic transfer of tax receipts to regions further narrow the room for manoeuvre. The next administration, analysts note, will inherit a fiscal starting point where stabilising public debt demands deeper primary-surplus consolidation than officially acknowledged.

Against that policy strain, laboratory science is uncovering biological levers that may one day shift the trajectory of healthspan. Researchers at Leiden University Medical Center, studying 212 long-lived sibling groups, identified a rare variant in the CGAS gene that appears to dampen chronic inflammation without crippling acute immune defence. The finding, presented at the European Society of Human Genetics congress, remains at the association stage; the team is now introducing the mutation into killifish—a short-lived vertebrate—to test whether it extends healthy lifespan in vivo. Separately, University of Queensland scientists used Mendelian randomisation on 160,000 UK Biobank participants to link taste-and-smell gene variants to food preferences and disease risk, finding that individuals genetically inclined to enjoy onion flavours showed lower rates of hypertension and type-2 diabetes. An Oxford demographer, however, warns that much extreme-longevity data rest on paperwork errors and pension fraud, and that epigenetic clocks calibrated against such records may be unreliable; he urges physical verification methods such as radiocarbon dating of eye-lens proteins.

Longevity’s gender skew adds a further layer. Australian men born today can expect to live to 81, four years fewer than women, a gap partly explained by the “unguarded X” hypothesis. Yet women’s longer lives often unfold in worse economic conditions: in Buenos Aires, 75 percent of domestic-violence victims over 60 are female, and sons are the aggressors in 52 percent of cases. The immediate milestone to watch is Colombia’s 2027 budget presentation, which will test whether the austerity spirit invoked in the fiscal framework translates into line-item cuts. In the laboratory, the killifish experiments will provide the first in-vivo readout on the CGAS variant’s effect on healthspan.